The impact of CYP3A5*1/*3, PIA1/A2 and T744C polymorphisms on clopidogrel and acetylsalicylic acid response variability in Mexican population. [electronic resource]
Producer: 20130131Description: e67-72 p. digitalISSN:- 1879-2472
- Acute Coronary Syndrome -- drug therapy
- Aspirin -- therapeutic use
- Clopidogrel
- Comorbidity
- Cytochrome P-450 CYP3A -- genetics
- Drug Resistance -- genetics
- Female
- Genetic Predisposition to Disease -- epidemiology
- Genetic Variation -- genetics
- Humans
- Male
- Mexico -- epidemiology
- Middle Aged
- Platelet Aggregation Inhibitors -- therapeutic use
- Platelet Glycoprotein GPIIb-IIIa Complex -- genetics
- Polymorphism, Single Nucleotide -- genetics
- Prevalence
- Receptors, Purinergic P2Y12 -- genetics
- Risk Factors
- Thrombosis -- epidemiology
- Ticlopidine -- analogs & derivatives
- Treatment Outcome
No physical items for this record
Publication Type: Controlled Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.